Introduction
Infertility is a rising health problem that leads to reduced fecundity rates in developed countries. As a consequence, more couples turn to ART to overcome childlessness and age-related infertility (Dyer et al., 2016) . On the other hand, the increased access to ART provides the opportunity for more couples to better plan and manage pregnancies. Since the birth of the first 'test tube baby' (Steptoe and Edwards, 1978) , over 6 million children have been conceived via ART and fertility treatments have become standard care in many countries (Maheshwari et al., 2016) . Despite the progress made in clinical and laboratory ART protocols, including embryo selection for transfer, the pregnancy rate per embryo transfer after ART still lingers at around 30% worldwide (Dyer et al., 2016) .
Embryonic chromosomal aneuploidy is a major factor contributing to embryo implantation failure as well as spontaneous miscarriage and may explain the relatively low success rate of IVF procedures (Vanneste et al., 2009b) . Studies on human IVF preimplantation embryos have revealed a remarkably high incidence of chromosomal instability (CIN) with 70-90% of cleavage-stage embryos carrying at least one aneuploid cell (Vanneste et al., 2009a, b; Voet et al., 2011; Chow et al., 2014; Huang et al., 2014; Zamani Esteki et al., 2015) . Moreover, terminal deletions and duplications are also found in naturally conceived newborns (Riegel et al., 2001) . In addition, several cases of mosaic individuals, exhibiting mixoploidy or chimaerism have also been well documented (Jarvela et al., 1993; Edwards et al., 1994; Yamazawa et al., 2010) . Therefore, we hypothesized that CIN would also occur at similar rate in vivo. Due to the ethical and legal constraints associated with human embryo research, naturally conceived human cleavage-stage embryos are not accessible, and CIN in human IVF and in vivo embryos cannot be compared directly. As an alternative, animal models have been widely used for investigating chromosomal abnormalities in in vivo and in vitro preimplantation embryos (Viuff et al., 2001; Rambags et al., 2005; Coppola et al., 2007) . However, the major limitation of previous studies was the application of low-resolution karyotyping methods that can neither detect CIN at the single-cell level nor reveal subtle sub-chromosomal aberrations. Thus, the knowledge about the genomic stability of in vivo-conceived embryos remained limited, largely due to the lack of robust genome analysis technologies.
To compare in vitro versus in vivo CIN directly, we used bovine cleavage-stage embryos, which represent a suitable model mimicking human early embryogenesis (Menezo and Herubel, 2002; Destouni et al., 2016) . In addition, similarly to human only 40-55% of dairy cows produce an offspring after single insemination (Diskin et al., 2012) , and aneuploidy was reported in one-fifth of bovine aborted fetuses and non-viable neonates (Coates et al., 1988) . We applied a genome-wide single-cell analysis method that enabled haplotyping and copy-number profiling, called haplarithmisis (Zamani Esteki et al., 2015) , on all individual bovine blastomeres obtained from in vivo embryos derived from oocytes that were matured and fertilized in vivo after ovarian stimulation of donor animals (referred to as in vivo embryos). In parallel, we tested in vitro-produced embryos derived from in vitro matured and fertilized oocytes that were retrieved from the same donor animals using ovarian stimulation and ovum pick up (referred to as OPU-IVF embryos) and in vitro-produced embryos derived from in vitro matured and fertilized oocytes that were retrieved from donor animals without ovarian stimulation (referred to as IVM-IVF embryos). All single blastomeres were analyzed for the presence of chromosomal aberrations.
Materials and Methods

Ethical approval
This study was approved by the Ethical Committee of the Faculty of Veterinary Sciences of Ghent University, Belgium (EC2013/197, EC2015/71).
Study design
The aim of the study was to evaluate CIN in naturally conceived preimplantation embryos. In parallel, we investigated the influence of different IVF procedures on embryo development using bovine as a model for human early embryogenesis (Menezo and Herubel, 2002; Destouni et al., 2016) . Five young, healthy, cycling Holstein Friesian heifers (Bos taurus) between 18 and 36 months of age were used as oocyte and embryo donors. All donor cows were subjected to hormonal stimulation with subsequent ovum pick up or in vivo embryo collection (Besenfelder et al., 2008) . Blood samples from the donor cows (mothers) and semen from the bull (father) were used to extract bulk DNA (DNeasy Blood and Tissue kit, Qiagen, Germany). Bulk DNA was also obtained from the parents of the bull (paternal grandparents) and the available parents of the cows (maternal grandparents; only for crosses 4757, 8301 and 9617). After hormonal treatments, the cows were left untreated for one month before they were slaughtered. After collection of ovaries, oocytes were retrieved and embryos were produced in vitro by routine procedures (Catteeuw et al., 2017) . Subsequently, single blastomeres were isolated, whole-genome amplified (WGA) and hybridized on BovineHD BeadChip arrays (Illumina Inc., USA). The acquired array data was used for single-cell genome-wide haplotyping and copy-number profiling (Zamani Esteki et al., 2015) .
Media and reagents
Basic Eagle's Medium amino acids, Minimal Essential Medium (MEM) nonessential amino acids (100×), TCM-199-medium, kanamycin and gentamycin were purchased from Life Technologies Europe (Ghent, Belgium) and all other components were obtained from Sigma (Schnelldorf, Germany), unless otherwise stated. All the media were filter-sterilized using a 0.22 μm filter (Pall Corporation, Ann Arbor, MI, USA) before use.
Stimulation protocol and ovum pick up
Stimulation protocol for ovum pick up was used to generate OPU-IVF embryos and was performed 3 to 6 times in all animals with at least one week interval between OPU sessions. On Day 0, heifers were given an epidural anesthesia using 3 ml of Procaine Hydrochloride 2% (VMD, Belgium) to decrease peristalsis and discomfort. An ultrasound probe was inserted in the vagina, and follicles larger than 5 mm were removed by puncturing the ovaries. Animals received dinoprost (prostaglandin F2α (PGF 2α )) intramuscularly (i.m.) (Dinolytic ® , Zoetis, Belgium), and a CIDR (controlled internal drug release, Progesterone, Zoetis, Belgium) was administered in the vagina. In following days, pFSH injections (Stimufol ® , Reprobiol, Belgium) were given i.m. twice a day. The CIDR was removed 40-44 h after the last pFSH injection and OPU was performed. On the day of OPU animals were given an epidural anesthesia using 3 ml of Procaine Hydrochloride 2%. All follicles were aspirated using an ultrasound probe, a 7.5 MHz transducer and a stainless steel guide. Puncturing was performed using disposable 19 G needles connected to a 50 ml tube via silicon tubing. Needles were changed between ovaries of the same animal and between animals, further tubing was also renewed between animals. Follicular fluid containing the oocytes was collected in 5 ml HEPES-buffered TCM-199 supplemented with 18 IU/ml heparin, 50 μg/ml gentamicin and 0.1% fetal calf serum (FCS). Immediately following recovery, the collected follicular fluid was filtered through a 75 μm mesh filter with HEPES-buffered TCM-199. Oocytes were grouped per donor and embryos were produced according to the standard in vitro embryo production protocol.
In vitro bovine embryo production protocol
Bovine OPU-IVF and IVM-IVF embryos were produced per donor by previously described methods (Catteeuw et al., 2017) . Briefly, oocytes retrieved via ovum pick up and oocytes retrieved from ovaries of slaughtered animals were placed per donor in 500 μl maturation medium, consisting of modified bicarbonate-buffered TCM-199 supplemented with 50 μg/ml gentamycin and 20 ng/ml epidermal growth factor (EGF) for 22 h at 38.5°C in 5% CO 2 in humidified air. After maturation, frozenthawed semen of a previously tested Holstein Friesian bull was used for fertilization. Spermatozoa were separated over a discontinuous Percoll gradient (45 and 90%; GE Healthcare Biosciences, Uppsala, Sweden) and sperm concentration was adjusted to 1 × 10 6 spermatozoa/ml using IVF-TALP (Tyrode's Albumin Lactate Pyruvate), which is supplemented with 6 mg/ml BSA (Sigma A8806) and 25 μg/ml heparin. Matured oocytes were incubated per donor in 500 μl IVF-TALP with spermatozoa for 21 h at 38.5°C in 5% CO 2 in humidified air. Presumptive zygotes were transferred to synthetic oviductal fluid (SOF) supplemented with essential and non-essential amino acids (SOFaa), 0.4% BSA (Sigma A9647) and ITS (5 μg/ml insulin, 5 μg/ml transferrin and 5 ng/ml selenium) and were placed per donor in a droplet of culture medium. The droplet size differed between donors depending on the number of zygotes, an embryo:medium ratio of 1:2 was maintained with a minimal droplet size of 20 μl. Each droplet was covered by mineral oil and incubated at 38.5°C in 5% CO 2 , 5% O 2 and 90% N 2 .
Oviductal flush and collection of in vivo embryos
The in vivo collection of embryos was performed by oviductal flush as described earlier (Besenfelder et al., 2008) . First, estrous cycles of the donor animals were pre-synchronized by i.m. administering 2 ml PGF 2α (500 μg Cloprostenol, Estrumate, Belgium) twice within 11 days. Fortyeight hours after both PGF 2α treatments, the animals received i.m. About 21 μg Gonadotropin Releasing Hormone (GnRH) (Receptal ® , MSD AH, Belgium). Dominant follicles were ablated 9 days after heat detection. Thirty-six hours later, pFSH was administered in decreasing dosages twice a day for 4 days (1.5, 1.4, 1.2, 1.1, 0.8, 0.6, 0.5 and 0.5 ml), and in total 380 μg follitropine was given. The donor animals received two PGF 2α treatments 60 and 72 h after the initial pFSH treatment. Finally, 24 h after the last pFSH treatment, 21 μg GnRH was administered to induce ovulation, simultaneously animals were inseminated with frozen-thawed semen. Artificial insemination (AI) was repeated 12 and 24 h later. Embryos were flushed bilaterally 36 h after the last AI. Briefly, donor animals were given epidural anesthesia using 5 ml of Procaine Hydrochloride 2%. An embryo flushing catheter was directed through the cervix and fixed in the uterine horn. An integrated device consisting of a universal tube, an endoscope and flushing system was inserted through the vaginal wall into the peritoneal cavity, which was passively filled with air. Oviducts were flushed with 40-60 mL flushing medium (PBS supplemented with 1% FCS) to pass the embryos through the uterotubal junction. Once in the uterine horn, flushing medium containing the embryos was collected via the uterus flushing catheter into an embryo filter. Finally, the uterine horn was flushed with another 300-500 mL medium through the uterine flushing catheter. This procedure was repeated for flushing the other oviduct and uterine horn. The collected medium was transferred to petri dishes and examined for embryos using a stereomicroscope.
Single blastomere isolation and SNP genotyping
IVM-IVF, OPU-IVF and in vivo-derived embryos were treated with pronase (0.1% protease for IVM-IVF and OPU-IVF embryos and 1% protease for in vivo embryos from S. griseus, Sigma P88110) in Hepes-buffered TCM-199 (Life Technologies Europe, Belgium) to dissolve zona pellucida. The zona-free embryos were then washed in HEPES-buffered TCM-199 with 10% FCS followed by Ca
+2
/Mg +2 free PBS with 0.05% BSA to stimulate blastomere dissociation. Next, each blastomere was washed three times in wash medium (Ca
/ Mg +2 free PBS with 0.1% polyvinylpyrrolidone)
and subsequently transferred into a 0.2-mL PCR tube containing 2 μl of PBS and WGA using a commercial multiple displacement amplification kit according to the manufacturer's fast 3 h protocol (REPLI-g Single Cell Kit, Qiagen, Germany). WGA products were purified with SPRI-beads (Beckman Coulter Inc., USA) at 0.8× total reaction volume and SNP genotyped on BovineHD SNP arrays using the Infinium HD whole-genome genotyping assay. Genotyping data obtained in this study has been submitted to NCBI Gene Expression Omnibus (GEO; accession number GSE95358; http://www.ncbi.nlm.nih.gov/geo/).
Single blastomere whole-genome analysis SNP genotypes, logR Ratio (logR) and B Allele Frequency (BAF) values were obtained for each sample by applying the GenCall algorithm, embedded in the GenomeStudio software Genotyping Module v.3.1 (Illumina Inc.). SNP genotypes were called by setting the GenCall score at 0.75. Next, computational workflow 'siCHILD-bovine' was used to acquire genome-wide haplarithm plots for each sample as described previously (Destouni et al., 2016) . Briefly, the acquired single-cell SNP data underwent quality control (QC) using a combination of unsupervised hierarchical clustering on the discrete SNP genotype calls and cumulative chromosome-specific standard deviation on the logR-values. Substandard samples were excluded from further investigations. The entire process of haplarithmisis was then applied for data analysis as previously described (Zamani Esteki et al., 2015) . Briefly, haplarithmisis uses single-cell SNP BAF-values and phased parental genotypes to determine genome-wide haplotypes, copy-number state of the haplotypes, as well as the parental and segregational origin of putative haplotype anomalies in the cell. The parental genotypes are phased via SNP genotype calls derived from a close relative, e.g. sibling or the grandparents. In this study, we have used paternal and maternal grandparents. Next, specific combinations of phased parental genotypes are retrieved that consequently define single-cell SNP BAF-values. Consequently, these values are plotted on paternal and maternal haplarithms. All the haplarithm plots obtained from this study are provided in Supplementary Figure S3 . In parallel with haplarithmisis, genome-wide haplotypes of single blastomeres were also reconstructed. Data were visualized with siCHILD, Circos (Krzywinski et al., 2009 ) and R (https://www.r-project.org/).
Statistical analysis
Statistical calculations were carried out using GraphPad Prism 6 software (GraphPad Software Inc., USA). The prevalence of CIN and the nature of detected chromosomal abnormalities were compared between the three embryo groups and corresponding single blastomeres by two-tailed Fisher's exact test with Bonferroni correction for multiple testing. The differences in the frequencies of CIN between the three embryo cohorts were considered to be statistically significant when the multiple testing corrected P-value was < 0.01. When comparing monospermic embryos, a P-value <0.05 was considered to be statistically significant.
Results
Embryo collection and genome-wide analysis of single bovine blastomeres
Five healthy, cycling Holstein Friesian heifers (Bos taurus) were used to produce IVM-IVF, OPU-IVF and in vivo embryos (Fig. 1A) , and the incidence of CIN was evaluated for all three groups. The use of the same cows and bull seed to study the effect of CIN in vivo and in vitro reduces potential genetic background confounding effects. First, donor animals were subjected to varying numbers of ovum pick up sessions depending on the ovarian response to hormonal stimulation and the number of oocytes retrieved per session (Table S1 ). Overall, 49 oocytes were collected, of which 13 (26.5%, n = 49) were good quality oocytes with homogeneous non-granulated cytoplasm and at least three compact layers of cumulus cells. On Day-1 post-insemination (pi), 28 (57.1%, n = 49) of the presumed zygotes cleaved, and subsequently 77 single blastomeres were collected from 10 OPU-IVF embryos on Day-2 pi (median 5.0 blastomeres per embryo) and five OPU-IVF embryos on Day-3 pi (median 6.0 blastomeres per embryo). Next, a total of 42 in vivo oviductal-stage embryos were retrieved on Day-2 pi by oviduct flushing (Besenfelder et al., 2008) , from which 34 (81.0%) have cleaved. Due to ovarian stimulation and OPU, the cow from cross 4757 developed scar tissue and no flushing of in vivo embryos was possible, because of the obstruction of the oviduct. Of all the cleaved in vivo embryos, 12 either had indigestible zona pellucida or lysed during washing and single-cell collection. As a result, 22 zonafree embryos were collected (median 4.45 blastomeres per embryo) and 18 were hybridized on SNP arrays after successful amplification of at least half of the blastomeres per embryo (n = 73).
Following OPU-IVF and in vivo embryo collection, donor animals were slaughtered, ovaries were collected, and in vitro embryos were produced (Catteeuw et al., 2017) . Thirty-one oocytes were aspirated, of which 16 (51.6%, n = 31) were of good quality. On Day-1 pi, 20 (64.5%, n = 31) of the presumed zygotes cleaved. Subsequently, 72 blastomeres were isolated from 13 Day-2 pi IVM-IVF embryos (mean 5.54 blastomeres per embryo) and further analyzed.
In summary, a total of 222 individual bovine blastomeres were collected from 13 IVM-IVF, 15 OPU-IVF and 18 in vivo-derived bovine cleavage-stage embryos. Following QC and initial data analysis, 171 (77.0%, n = 222) blastomeres were considered for further data interpretation (66 blastomeres from 13 IVM-IVF embryos, 46 blastomeres from 13 OPU-IVF embryos and 59 blastomeres from 16 in vivo-derived embryos, respectively; Table S2 ). For crosses 4757, 8301 and 9617 we applied haplarithmisis using both maternal and paternal grandparents as seeds for parental genotype phasing to reconstruct haplotypes of single blastomeres (Fig. 1B-C) . For crosses 4006 and 4770, lacking maternal grandparental DNA samples, only parents of the bull were used as a seed for creating the paternal haplarithm profile.
Characteristics of CIN in embryos developed in vitro and in vivo
We first aimed to assess the prevalence of CIN in IVM-IVF, OPU-IVF and in vivo-derived bovine cleavage-stage embryos. To evaluate the genomic stability of embryos, we investigated chromosome segregation patterns in all analyzed blastomeres (n = 171, Supplementary  Fig. S1 ). In this analysis, euploid blastomeres, irrespective of their ploidy, that lacked full chromosome or segmental aberrations were scored as balanced. The genomic integrity of single blastomeres was higher in in vivo embryos than in OPU-IVF and IVM-IVF embryos (in both cases P < 0.0001, Fisher's exact test; Fig. 2A) . At the embryonic level, the number of abnormal embryos carrying at least one blastomere with a full or segmental chromosomal aberration increased from 18.8% in in vivo embryos (3/16) up to 84.6% in IVM-IVF embryos (11/13) (P < 0.001, Fisher's exact test; Fig. 2B ). The CIN rate in OPU-IVF embryos (69.2%, 9/13) was comparable to the CIN rate in IVM-IVF embryos (P > 0.05, Fisher's exact test), but was higher than in in vivo-derived embryos (P < 0.01, Fisher's exact test). Because OPU-IVF group also contained five Day-3 pi embryos that may have undergone at least one more cell division that can lead to mitotic error, we decided to analyze Day-2 pi OPU-IVF embryos (n = 8) separately to obtain more consistency between the groups. Comparison of Day-2 OPU-IVF and in vivo embryos provided similar results, demonstrating that CIN is higher in Day-2 pi OPU-IVF embryos (75%, 6/8) than in in vivo-derived Day-2 pi embryos (P = 0.02, Fisher's exact test). Likewise, OPU-IVF embryos contained significantly larger proportion of unbalanced blastomeres that can subsequently lead to altered embryonic development (16/26, 61.5%, P < 0.0001, Fisher's exact test).
Next, we determined the nature of chromosomal aberrations in in vitro-produced and in vivo-derived embryos. As was expected, aneuploidy was the most prevalent type of error and all abnormal in vivoderived, OPU-IVF and IVM-IVF embryos contained whole-chromosome aberrations. Therefore, the number of embryos with aneuploidy was significantly higher in OPU-IVF embryos (69.2%, 9/13) and in IVM-IVF embryos (84.6%, 11/13) than in the in vivo group (18.8%, 3/16, P < 0.01 and P < 0.001, respectively, Fisher's exact test; Fig. 3A ). Meiotic errors were observed only in Cross 9617, once within the OPU-IVF group and once within the IVM-IVF group, in which case the embryos showed the same chromosomal aneuploidy in all of the sister blastomeres (OPU-IVF E01_Cross9617 and IVM-IVF E09_Cross9617 were monosomic for chromosomes 26 and 24, respectively; Supplementary  Fig. S1 ). The remaining aberrations were of mitotic origin and resulted in either whole chromosome or segmental imbalances. Segmental imbalances were most prevalent in IVM-IVF embryos (9/13, 69.2%) when compared to OPU-IVF embryos (2/13, 15.4%, P = 0.01, Fisher's exact test) and in vivo embryos (1/16, 6.3%, P = 0.001, Fisher's exact test; Fig. 3A) .
We also observed a number of embryos that had at least one blastomere with an abnormal ploidy state (Fig. 3A) . Single-cell haplarithm profiles uncovered the presence of only paternal (androgenetic) or only maternal (gynogenetic) genomes in a single blastomere and enabled triploid blastomeres to be classified as diandric or digynic in origin. Upon comparing IVM-IVF, OPU-IVF and in vivo embryos, we observed that IVM-IVF embryos were burdened with mixoploidy. In this study, mixoploidy is defined by the presence of cell lineages of different parental origin and/or different genome-wide ploidy states within the same embryo. As such, mixoploid embryos harbor simultaneously haploid, diploid and/or triploid cells (Fig. 3B, Supplementary  Fig. S1 ). Mixoploidy in IVM-IVF embryos can be attributed to the dispermic fertilization (69.2%, 9/13) that was identified by the presence of two different paternal haplotypes within the same embryo. In seven IVM-IVF embryos one of the extra paternal genomes segregated into a separate androgenetic cell line carrying only paternal DNA, a phenomenon that was recently discovered in in vitro-produced bovine cleavage-stage embryos and termed heterogoneic cell division (Destouni et al., 2016) . For example, a 10-cell IVM-IVF embryo contained eight androgenetic blastomeres, one biparental and one triploid blastomere (E10_Cross4770, Fig. 3B ). In addition, we observed amplified shattered paternal chromosomal DNA fragments and no maternal DNA in blastomere Bl005 of E07_Cross4770 ( Supplementary Fig. S1 ), and in E11_Cross4770 two blastomeres (Bl002 and Bl003) contained residues of paternal DNA that were reciprocal in nature ( Supplementary Fig. S1 ). Such replication and division of the remnants of sperm genome were also observed in a previous study on bovine in vitro-produced embryos (Destouni et al., 2016) . In contrast, only one OPU-IVF embryo underwent dispermic fertilization resulting in a diandric triploid embryo (E03_Cross4757, Fig. S1 ). Notably, no abnormal fertilization events occurred in the in vivo-derived embryos.
Because dispermy might influence CIN in embryos, we then analyzed only those embryos that developed from monospermic zygotes. For this purpose, we combined monospermic IVM-IVF (n = 4) and OPU-IVF (n = 12) embryos into a single group (referred to as in vitro) and compared them to in vivo-derived embryos (n = 16). The CIN rates confirmed a considerable difference between the in vitro-produced and cultured embryos, and in vivo-derived embryos (10/16, 62.5% vs 3/16, 18.8%, P = 0.03, Fisher's exact test; Fig. S2A ). In addition, it was clear that in vitro procedures had a highly significant negative impact on CIN, when we compared the low frequency of chromosomal aberrations and aberrant ploidy states in blastomeres of in vivo-derived embryos (7/59, 11.9%) with the high frequency chromosomal aberrations and aberrant ploidy states of in vitro-produced and cultured embryos (27/57, 47.4%, P < 0.0001, Fisher's exact test; Fig. S2B ). Similarly, when analyzing only Day-2 pi embryos, seven in vitro embryos were classified as abnormal (7/11, 63.6%, P = 0.04), while the total number of abnormal blastomeres in the in vitro group reached up to 45.9% (17/37, P < 0.001, Fisher's exact test). Together, these results strongly suggest that in vitro procedures, such as maturation, fertilization and culture, enhance embryonic CIN and consequently impede embryo developmental potential.
Discussion
Over the past decades, we have witnessed a profound impact of assisted reproduction on society, as the use of ART continues to increase globally. The number of women voluntarily or involuntarily delaying motherhood is also steadily increasing, and for those women, fertility preservation and IVF procedures are becoming a mainstream approach to achieve motherhood (Lallemant et al., 2016) . In this study, we applied an advanced genome analysis method to scrutinize the characteristics of chromosomal aberrations in in vivo-derived embryos and to investigate the potential influence of ART treatments on the rate and nature of CIN during early embryo development. We demonstrated that the genomic stability of in vivo embryos is significantly higher compared to OPU-IVF and IVM-IVF embryos.
Because only 30% of human conceptions result in live births (Macklon et al., 2002) and because chromosomal abnormalities can be detected in at least half of all spontaneous miscarriages (Menasha et al., 2005; Levy et al., 2014) , it was speculated that post-zygotic events leading to CIN in IVF embryos would also occur at similar frequency in naturally conceived embryos. However, in contrast to the initial hypothesis, CIN was found to be significantly more frequent in in vitro-produced rather that in vivo-derived bovine embryos. Since CIN was observed in less than 20% of in vivo embryos compared to at least 70% in in vitro embryos, in vivo-conceived embryos will most likely be overall more viable. This observation has two major implications: (i) directing individuals towards ART programs should be done cautiously as it may compromise embryo quality and (ii) improvements to the embryo in vitro environment are likely still possible to enhance ART success.
When oocytes are matured in vivo, they originate from ovulatory follicles that undergo strongly regulated processes of selection, growth and dominance, until LH surge induces the meiotic maturation of the fully grown oocytes into fertilizable oocytes (Li and Albertini, 2013) . In addition, during preimplantation embryo development in vivo, the female reproductive tract provides the appropriate environment and the essential nutrition that guide physiological processes of mammalian early embryogenesis (Gardner et al., 1996) . In contrast, during preimplantation embryo development in vitro, even minor alterations during in vitro culture and the micromanipulation of oocytes and embryos may negatively impact embryo quality and subsequent fetal development (Wale and Gardner, 2016) . Indeed, a study in cattle investigated the separate effect of in vitro procedures (maturation, fertilization and culture) on embryo developmental potential, and it was clear that in vivo oocyte maturation and in vivo embryo development show consistently more favorable outcome in terms of embryo quality The proportion of normal diploid embryos and aberrant embryos in IVM-IVF (n = 13), OPU-IVF (n = 13) and in vivo group (n = 16); **P < 0.01, ***P < 0.001, two-tailed Fisher's exact test for multiple testing. QC, quality control. compared to in vitro conditions (Rizos et al., 2002) . Moreover, the oocyte plays a central role in maintaining genomic integrity before major embryonic genome activation (EGA), as first post-zygotic divisions are highly dependent on the large pool of maternal mRNAs and proteins provided by the oocyte (Braude et al., 1988) . This view is supported by the time-lapse study, demonstrating that the generation of embryonic aneuploidy precedes the major wave of EGA (Chavez et al., 2012) , while the inheritance of an aberrant oocyte transcriptome has been associated with abnormal first post-zygotic cleavage (VeraRodriguez et al., 2015) . Therefore, in the current study, the higher rate of chromosomal abnormalities in in vitro embryos may also arise from the defective maternal resources of the oocytes; however more research should target the precise impact of the intrinsic quality of the oocyte on the incidence of chromosomal aberrations in cleavage-stage embryos. Finally, although it was recently demonstrated that mosaic embryos may be viable, as abnormal cells get depleted during embryo development, there needs to be a sufficient proportion of normal cells within the embryo to ensure its survival (Bolton et al., 2016) . Moreover, aneuploid cells in trophectoderm lineage were proposed to contribute to the formation of confined placental mosaicism (Robberecht et al., 2010) , a condition that has been associated with intrauterine growth restriction (Wilkins-Haug et al., 2006; Baffero et al., 2012) .
Controlled ovarian stimulation (COS) is widely used in women to retrieve numerous oocytes for fertilization per cycle and to enhance the cumulative pregnancy rate. In humans, COS is considered to be a safe procedure, since embryo quality, implantation rates and pregnancy outcomes are comparable between stimulated and natural IVF cycles (Ziebe et al., 2004; Sunkara et al., 2016) . In our study, although both in vivo and OPU-IVF embryos were obtained after hormonal stimulation of donor animals, we observed more chromosomally normal diploid embryos and blastomeres in in vivo-derived embryos than in OPU-IVF embryos. This indicates that in vitro maturation, fertilization and culture are the major causes of embryonic CIN, rather than ovarian stimulation itself. This further suggests that improvements in culture conditions are necessary to increase IVF success rates. However, there is still an ongoing debate on the potential deleterious effect of ovarian stimulation on oocyte and embryo quality, so the technology of human IVM of retrieved oocytes with no or very little follicle stimulating hormone (FSH) stimulation has been proposed as an alternative approach to conventional ovarian stimulation followed by IVF (Dal Canto et al., 2006; Ellenbogen et al., 2014) . Although in humans, achieving pregnancy and live birth via IVM is less successful than by using conventional IVF (Buckett et al., 2008; Gremeau et al., 2012) , it is a much safer and beneficial option for women with polycystic ovaries or cancer patients for whom hormonal stimulation is contraindicated. The main advantage of using IVM in humans is the ability to eliminate the risk of developing ovarian hyperstimulation syndrome, a possible life-threatening complication, and to reduce the overall cost associated with hormonal therapy. In human IVM procedure, subsequent oocyte fertilization is typically performed by intracytoplasmic sperm injection (ICSI), but traditional IVF (human IVM-IVF) has also been used to fertilize in vitro matured oocytes (Soderstrom-Anttila et al., 2005; Walls et al., 2012) . However, the IVM-IVF combination may be suboptimal for humans because in vitro matured oocytes have no contact with the oviductal environment, which enables the oocyte to reach full cytoplasmic maturation that modifies zona pellucida resistance, and thus zona pellucida of IVM oocytes may become less resistant to dispermic fertilization under in vitro conditions (Xia, 2013) . Our results seem to corroborate this view as dispermic fertilization was almost exclusively found among IVM-IVF embryos. In addition, we observed that dispermic embryos segregate their extra paternal genome into a separate androgenetic cell lineage (Destouni et al., 2016) leading to mixoploidy. These embryos would have a low developmental potential, but due to a highly proliferative cell lineage carrying paternal genome only, they would have a higher implantation capacity and could potentially give rise to molar pregnancies of androgenetic origin. Complete hydatidiform moles of androgenetic origin have been reported in both human (Ibrahim et al., 1989; Kwon et al., 2002; Sun et al., 2012; Obeidi et al., 2015) and in cattle (Meinecke et al., 2002) . Taken together, our results can possibly explain why IVM of human Abnormal ploidy state of blastomeres was not considered in evaluating whole-chromosome aberrations to avoid bias; for whole-chromosome aberrations P-values stand as **P < 0.01, ***P < 0.001; for segmental imbalances and aberrant ploidy P-values stand as **P = 0.01, ***P = 0.001, two-tailed Fisher's exact test for multiple testing. (B) Examples of embryos containing at least one blastomere with an abnormal ploidy status. The stacked bar plots depict the number of blastomeres with different genomic anomalies per embryo. Blastomeres with normal karyotype and with single aneuploidies and/or segmental losses or gains that have both maternal and paternal alleles present in their genome (diploid embryos) are depicted in black.
eggs and subsequent IVF and embryo culture are associated with lower reproductive success rate (Pfeifer et al., 2013) .
Unfortunately, studies of in vivo embryogenesis rely on appropriate animal models and direct research of in vivo human embryogenesis awaits novel technical approaches. Another limitation of our study is the small number of embryos analyzed, and because some of the cells did not pass the QC, it was also not possible to determine the chromosomal status of those QC-failed blastomeres. In addition, due to small cohort sizes, we were not able to compare the pedigrees between each other to determine any cow-specific confounding factors, influencing the frequency of aneuploidy in embryos. Thus more studies are warranted to corroborate our findings. Also, in vivo-derived embryos do not entirely represent the natural conception, as donor cows underwent hormonal stimulation to increase the number of in vivo-derived embryos via oviductal flush. Moreover, the ovarian response to hormonal treatment is unpredictable and can vary from cycle to cycle, and may result in either 'low' or 'high' response to hormone treatment both in cattle (De Roover et al., 2005; Durocher et al., 2006) and human (Broekmans et al., 2014; Rombauts et al., 2015) . Although the difference in oocyte and embryo quality after ovarian stimulation between donor animals was also noticed in this study, future research is needed to evaluate the impact of hormonal stimulation on CIN in embryos. However, the overall reduced CIN in in vivo embryos compared to OPU-IVF embryos suggests that the effect of hormonal stimulation will be minor.
In summary, this is the first study to date that compared simultaneously the impact of three different embryo production protocols on subsequent embryo development using single-cell technologies. We showed that in vitro environment influence CIN and compromises cleavage-stage embryo development and survival. This highlights the importance of understanding in vivo regulation of mammalian oocyte maturation and subsequent embryonic development to refine assisted reproductive technologies in human. Some caution to extrapolate the results to human IVF is required, since oocytes in both OPU-IVF and IVM-IVF study groups were in vitro matured prior to fertilization. This procedure is rarely used in human ART. Still, in the absence of human data, it is of paramount importance to propose ART only to those couples who have a medical indication for IVF treatment, while the use of IVF for social reasons should be critically discussed, taking into account possible complications associated with assisted reproduction.
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